Advanced search
Publication Cover
Leukemia & Lymphoma Volume 48, 2007 - Issue 8
Submit an article Journal homepage
302
Views
59
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Hodgkin lymphoma: Response assessment by Revised International Workshop Criteria

Lieselot Brepoels Departments of Nuclear MedicineCorrespondence[email protected]
,
Sigrid Stroobants Departments of Nuclear Medicine
,
Walter de Wever Radiology
,
Karoline Spaepen Departments of Nuclear Medicine
,
Peter Vandenberghe Centre of Human Genetics
,
Jose Thomas Clinical Oncology
,
Anne Uyttebroeck Pediatric Hemato-Oncology
,
Luc Mortelmans Departments of Nuclear Medicine
,
Christiane de Wolf-Peeters Pathology
&
Gregor Verhoef Hematology, University Hospital Gasthuisberg and Catholic University Leuven, Leuven, Belgium
 show all
Pages 1539-1547 | Received 01 Mar 2007, Accepted 27 Apr 2007, Published online: 01 Jul 2009

Citations (59)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Kuruva Manohar, Bhagwant Rai Mittal, Senthil Raja, Anish Bhattacharya, Pankaj Malhotra & Subhash Varma. (2013) Comparison of various criteria in interpreting end of therapy F-18 labeled fluorodeoxyglucose positron emission tomography/computed tomography in patients with aggressive non-Hodgkin lymphoma. Leukemia & Lymphoma 54:4, pages 714-719.
Read now
Daniel Molin, Hans Hagberg, Madis Suurküla & Gunnar Åström. (2010) Change of initial staging at early remission evaluation with FDG-PET/CT in Hodgkin lymphoma: A report of two cases. Acta Oncologica 49:4, pages 526-528.
Read now
Martin Hutchings. (2009) PET imaging in lymphoma. Expert Review of Hematology 2:3, pages 261-276.
Read now
Lieselot Brepoels, Sigrid Stroobants, Walter De Wever, Daan Dierickx, Peter Vandenberghe, Jose Thomas, Luc Mortelmans, Gregor Verhoef & Christiane De Wolf-Peeters. (2008) Positron emission tomography in mantle cell lymphoma. Leukemia & Lymphoma 49:9, pages 1693-1701.
Read now

Articles from other publishers (55)

Nicola M. Hughes, Heather A. Jacene, Sree Harsha Tirumani & Richard L. Wahl. 2020. Nuclear Oncology. Nuclear Oncology 1 45 .
Nicola M. Hughes, Heather A. Jacene, Sree Harsha Tirumani & Richard L. Wahl. 2022. Nuclear Oncology. Nuclear Oncology 431 474 .
Andrea Gallamini, Michał Kurlapski & Jan Maciej Zaucha. (2021) FDG-PET/CT for the Management of Post-Chemotherapy Residual Mass in Hodgkin lymphoma. Cancers 13:16, pages 3952.
Crossref
Andrea Gallamini, Andrea Rossi, Caterina Patti, Marco Picardi, Alessandra Romano, Maria Cantonetti, Sara Oppi, Simonetta Viviani, Silvia Bolis, Livio Trentin, Guido Gini, Roberta Battistini, Stephane Chauvie, Roberto Sorasio, Chiara Pavoni, Roberta Zanotti, Michele Cimminiello, Corrado Schiavotto, Piera Viero, Antonino Mulé, Federico Fallanca, Umberto Ficola, Corrado Tarella, Luca Guerra & Alessandro Rambaldi. (2020) Consolidation Radiotherapy Could Be Safely Omitted in Advanced Hodgkin Lymphoma With Large Nodal Mass in Complete Metabolic Response After ABVD: Final Analysis of the Randomized GITIL/FIL HD0607 Trial. Journal of Clinical Oncology 38:33, pages 3905-3913.
Crossref
Rahul V. Parghane & Sandip Basu. (2020) PET/Computed Tomography in Treatment Response Assessment in Cancer. PET Clinics 15:1, pages 101-123.
Crossref
Jan Maciej Zaucha, Stephane Chauvie, Renata Zaucha, Alberto Biggii & Andrea Gallamini. (2019) The role of PET/CT in the modern treatment of Hodgkin lymphoma. Cancer Treatment Reviews 77, pages 44-56.
Crossref
Celal ACAR, Vildan ÖZKOCAMAN, Ali Tayyar AKPINAR & Fahir ÖZKALEMKAŞ. (2019) Agresif B hücreli Hodgkin Dışı ve Hodgkin Lenfomada İlk Basamak Tedavi Yanıtının FDG-PET/BT ile Değerlendirilmesinde Rezidüel SUVmaxResidual SUVmax in FDG-PET/CT Evaluation after First-Line Treatment in Aggressive B-Cell Non-Hodgkin's and Hodgkin's Lymphoma. Uludağ Üniversitesi Tıp Fakültesi Dergisi 45:1, pages 5-11.
Crossref
Martin Hutchings. (2018) Improvements in Imaging of Hodgkin Lymphoma. The Cancer Journal 24:5, pages 215-222.
Crossref
L.M. Hodgson Reyes, I. Olarte Carrillo, C.O. Ramos Peñafiel, A. Martínez Tovar, E. Gallardo, H. Castellanos Sinco & J. Collazo Jaloma. (2018) Expression of cancer testis antigens in patients with Hodgkin's lymphoma and their clinical correlation. Revista Médica del Hospital General de México 81:1, pages 27-34.
Crossref
Sara Sheikhbahaei, Esther Mena, Puskar Pattanayak, Mehdi Taghipour, Lilja B. Solnes & Rathan M. Subramaniam. (2017) Molecular Imaging and Precision Medicine. PET Clinics 12:1, pages 105-118.
Crossref
Heather A. Jacene, Sree Harsha Tirumani & Richard L. Wahl. 2017. Nuclear Oncology. Nuclear Oncology 353 393 .
Federico Fallanca, Pierpaolo Alongi, Elena Incerti, Luigi Gianolli, Maria Picchio, Irfan Kayani & Jamshed Bomanji. (2016) Diagnostic accuracy of FDG PET/CT for clinical evaluation at the end of treatment of HL and NHL: a comparison of the Deauville Criteria (DC) and the International Harmonization Project Criteria (IHPC). European Journal of Nuclear Medicine and Molecular Imaging 43:10, pages 1837-1848.
Crossref
Wendy Atkinson, Ciprian Catana, Jeremy S. Abramson, Grae Arabasz, Shanaugh McDermott, Onofrio Catalano, Victorine Muse, Michael A. Blake, Jeffrey Barnes, Martin Shelly, Ephraim Hochberg, Bruce R. Rosen & Alexander R. Guimaraes. (2016) Hybrid FDG-PET/MR compared to FDG-PET/CT in adult lymphoma patients. Abdominal Radiology 41:7, pages 1338-1348.
Crossref
Mateen C. Moghbel, Lale Kostakoglu, Katherine Zukotynski, Delphine L. Chen, Helen Nadel, Ryan Niederkohr & Erik Mittra. (2016) Response Assessment Criteria and Their Applications in Lymphoma: Part 1. Journal of Nuclear Medicine 57:6, pages 928-935.
Crossref
Lasse H. Jakobsen, Martin Hutchings, Peter de Nully Brown, Johan Linderoth, Karen J. Mylam, Daniel Molin, Hans E. Johnsen, Martin B?gsted, Mats Jerkeman & Tarec C. El-Galaly. (2016) No survival benefit associated with routine surveillance imaging for Hodgkin lymphoma in first remission: a Danish-Swedish population-based observational study. British Journal of Haematology 173:2, pages 236-244.
Crossref
Ur Metser, Ravi Mohan, Vaughan Beckley, Hadas Moshonov, David Hodgson & Grainne Murphy. (2015) FDG PET/CT Response Assessment Criteria for Patients with Hodgkin’s and Non-Hodgkin’s Lymphoma at End of Therapy: A Multiparametric Approach. Nuclear Medicine and Molecular Imaging 50:1, pages 46-53.
Crossref
Heather A. Jacene, Sree Harsha Tirumani & Richard L. Wahl. 2016. Nuclear Oncology. Nuclear Oncology 1 42 .
Tarec Christoffer El‐Galaly, Martin Bjerregård Pedersen, Martin Hutchings, Karen Juul Mylam, Jakob Madsen, Anne Ortved Gang, Martin Bøgsted, Peter de Nully Brown, Annika Loft, Anne Lerberg Nielsen, Helle Westergreen Hendel, Victor Iyer & Lars Christian Gormsen. (2015) Utility of interim and end‐of‐treatment PET/CT in peripheral T‐cell lymphomas: A review of 124 patients. American Journal of Hematology 90:11, pages 975-980.
Crossref
Martin Hutchings & Sally Barrington. (2015) FDG-PET for the early treatment monitoring, for final response and follow-up evaluation in lymphoma. Clinical and Translational Imaging 3:4, pages 271-281.
Crossref
Priscilla Brito da Silva, Guilherme Fleury Perini, Luciana de Andrade Pereira, Elyse Moritz Sacconato, Adriana Marques Damasco Penna, Joao Garibaldi, Egyla Cavalcante & Otavio C.G. Baiocchi. (2015) Imbalance of Pro- and Anti-Inflammatory Cytokines in Patients With cHL Persists Despite Treatment Compared With Control Subjects. Clinical Lymphoma Myeloma and Leukemia 15, pages S151-S157.
Crossref
Anna M. Maffione, Rossella Paolini, Elisabetta Rodella, Cristina Ambrosio, Lucia Rampin, Laura C. Lisato, Maria Ballotta, Giovanni Pavanato & Domenico Rubello. (2015) Response criteria for malignant lymphoma. Nuclear Medicine Communications 36:4, pages 398-405.
Crossref
Andrea Gallamini, Martin Hutchings & Anna Borra. 2015. Hodgkin Lymphoma. Hodgkin Lymphoma 107 130 .
Adriano Massimiliano Priola, Giorgio Galetto & Sandro Massimo Priola. (2014) Diagnostic and functional imaging of thymic and mediastinal involvement in lymphoproliferative disorders. Clinical Imaging 38:6, pages 771-784.
Crossref
Andrea Gallamini & Anna Borra. (2014) Role of PET in Lymphoma. Current Treatment Options in Oncology 15:2, pages 248-261.
Crossref
Lale Kostakoglu & Bruce D. Cheson. (2014) Current role of FDG PET/CT in lymphoma. European Journal of Nuclear Medicine and Molecular Imaging 41:5, pages 1004-1027.
Crossref
Laura M. Kenny & Eric O. Aboagye. 2014. Emerging Applications of Molecular Imaging to Oncology. Emerging Applications of Molecular Imaging to Oncology 329 374 .
F. Ricard, C. Tychyj-Pinel, F. Giammarile, C. Houzard, A.-F. Manichon, F. Chateau & F. R?ty. (2013) Int?gration des crit?res m?taboliques de la TEP au 18FDG pour le choix des l?sions cibles en imagerie onco-h?matologique. M?decine Nucl?aire 37:6, pages 244-250.
Crossref
J.P. Pilkington Woll, A.M. García Vicente, M.P. Talavera Rubio, A.M. Palomar Muñoz, G. Jiménez Londoño, A. León Martín, C. Calle Primo & A.M. Soriano Castejón. (2013) Quantitative and qualitative evaluation of the interim PET/CT in lymphoma treatment in the prediction of complete metabolic response. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 32:2, pages 70-76.
Crossref
J.P. Pilkington Woll, A.M. García Vicente, M.P. Talavera Rubio, A.M. Palomar Muñoz, G. Jiménez Londoño, A. León Martín, C. Calle Primo & A.M. Soriano Castejón. (2013) Evaluación cuantitativa y cualitativa de la PET/TC a mitad del tratamiento en linfomas en la predicción de respuesta metabólica completa. Revista Española de Medicina Nuclear e Imagen Molecular 32:2, pages 70-76.
Crossref
C. Bodet-Milin, T. Eug?ne, T. Gastinne, C. Bailly, S. Le Gouill, B. Dupas & F. Kraeber-Bod?r?. (2013) La place de la TEP au FDG dans l??valuation des lymphomes en 2012. Journal de Radiologie Diagnostique et Interventionnelle 94:2, pages 164-174.
Crossref
C. Bodet-Milin, T. Eug?ne, T. Gastinne, C. Bailly, S. Le Gouill, B. Dupas & F. Kraeber-Bod?r?. (2013) The role of FDG-PET scanning in assessing lymphoma in 2012. Diagnostic and Interventional Imaging 94:2, pages 158-168.
Crossref
Ricardo Pérez‐Cuevas, Svetlana V. Doubova, Marta Zapata‐Tarres, Sergio Flores‐Hernández, Lindsay Frazier, Carlos Rodríguez‐Galindo, Gabriel Cortes‐Gallo, Salomon Chertorivski‐Woldenberg & Onofre Muñoz‐Hernández. (2012) Scaling up cancer care for children without medical insurance in developing countries: The case of Mexico. Pediatric Blood & Cancer 60:2, pages 196-203.
Crossref
Katrine Riklund. 2013. Imaging in Nuclear Medicine. Imaging in Nuclear Medicine 7 18 .
Heather A. Jacene & Richard L. Wahl. 2013. Nuclear Oncology. Nuclear Oncology 153 187 .
Martin Hutchings. (2012) How does PET/CT help in selecting therapy for patients with Hodgkin lymphoma?. Hematology 2012:1, pages 322-327.
Crossref
Mariane C. G. Assis, Antonio H. F. M. Campos, Jose S. R. Oliveira, Fernando A. Soares, Joyce M. K. Silva, Priscilla B. Silva, Adriana D. Penna, Eni M. Souza & Otavio C. G. Baiocchi. (2012) Increased expression of CD4+CD25+FOXP3+ regulatory T cells correlates with Epstein?Barr virus and has no impact on survival in patients with classical Hodgkin lymphoma in Brazil. Medical Oncology 29:5, pages 3614-3619.
Crossref
Rathan M. Subramaniam, Leonne Prompers, A. Agarwal, Ali Guermazi & Felix M. Mottaghy. 2012. PET-CT and PET-MRI in Oncology. PET-CT and PET-MRI in Oncology 211 227 .
Riguel J Inaoka, Achim A Jungbluth, Otávio CG Baiocchi, Mariane CG Assis, Nicole C Hanson, Denise Frosina, Jodie Tassello, Adriana B Bortoluzzo, Antonio C Alves & Gisele WB Colleoni. (2011) An overview of cancer/testis antigens expression in classical Hodgkin's lymphoma (cHL) identifies MAGE-A family and MAGE-C1 as the most frequently expressed antigens in a set of Brazilian cHL patients. BMC Cancer 11:1.
Crossref
Shingo Baba, Koichiro Abe, Takuro Isoda, Yasuhiro Maruoka, Masayuki Sasaki & Hiroshi Honda. (2011) Impact of FDG-PET/CT in the management of lymphoma. Annals of Nuclear Medicine 25:10, pages 701-716.
Crossref
R. Abgral, P.-Y. Le Roux, F. Blanc-Béguin, T. Eugène, S. Querellou, C. Bodet-Milin, F. Kraeber-Bodéré & P.-Y. Salaün. (2011) Évaluation de la réponse thérapeutique par tomographie par émission de positons (TEP) au 18fluoro-désoxyglucose (FDG) en oncologie-hématologie. Médecine Nucléaire 35:11, pages 600-607.
Crossref
J.M. Warwick & M.M. Sathekge. (2011) PET/CT scanning with a high HIV/AIDS prevalence. Transfusion and Apheresis Science 44:2, pages 167-172.
Crossref
A. Julian, T. Wagner, P. Payoux, A. Hitzel & J.-P. Esquerré. (2011) Évaluation de la réponse au traitement des lymphomes : rôle de la TEP-FDG. Médecine Nucléaire 35:1, pages 21-28.
Crossref
Martin Hutchings & Andrea Gallamini. 2011. Hodgkin Lymphoma. Hodgkin Lymphoma 77 95 .
Lena Specht & Martin Hutchings. 2011. Radiotherapy for Hodgkin Lymphoma. Radiotherapy for Hodgkin Lymphoma 161 166 .
Lieselot Brepoels, Marijke De Saint-Hubert, Sigrid Stroobants, Gregor Verhoef, Jan Balzarini, Luc Mortelmans & Felix M. Mottaghy. (2010) Dose-response relationship in cyclophosphamide-treated B-cell lymphoma xenografts monitored with [18F]FDG PET. European Journal of Nuclear Medicine and Molecular Imaging 37:9, pages 1688-1695.
Crossref
H. Mocikova, P. Obrtlikova, B. Vackova & M. Trneny. (2010) Positron emission tomography at the end of first-line therapy and during follow-up in patients with Hodgkin lymphoma: a retrospective study. Annals of Oncology 21:6, pages 1222-1227.
Crossref
G. Guida, B. Culla, T. Scirelli, G. Bellone, S. Sciascia, L. Brussino, D. Novero, G. Palestro, E. Heffler, P. Gavarotti, G. Rolla & C. Bucca. (2009) Exhaled Nitric Oxide and Nitric Oxide Synthase Expression in Hodgkin's Disease. International Journal of Immunopathology and Pharmacology 22:4, pages 1027-1034.
Crossref
C. Bodet-Milin, P.-Y. Salaun, C. Crespin, J.-P. Vuillez & F. Kraeber-Bod?r?. (2009) La place de la TEP au FDG dans l??valuation des lymphomes. M?decine Nucl?aire 33:8, pages 486-490.
Crossref
Martin Hutchings & Sally F. Barrington. (2009) PET/CT for Therapy Response Assessment in Lymphoma. Journal of Nuclear Medicine 50:Suppl 1, pages 21S-30S.
Crossref
Heather A. Jacene, Ross Filice, Wayne Kasecamp & Richard L. Wahl. (2009) 18 F-FDG PET/CT for Monitoring the Response of Lymphoma to Radioimmunotherapy . Journal of Nuclear Medicine 50:1, pages 8-17.
Crossref
Karl S. Peggs, Paolo Anderlini & Anna Sureda. (2008) Allogeneic transplantation for Hodgkin lymphoma. British Journal of Haematology.
Crossref
Lale Kostakoglu. (2008) Early prediction of response to therapy: the clinical implications in Hodgkin’s and non-Hodgkin’s lymphoma. European Journal of Nuclear Medicine and Molecular Imaging 35:8, pages 1413-1420.
Crossref
. (2008) Current Awareness in Hematological Oncology. Hematological Oncology 26:2, pages 115-122.
Crossref
Martin Hutchings & Lena Specht. (2008) PET/CT in the management of haematological malignancies. European Journal of Haematology 80:5, pages 369-380.
Crossref
Lale Kostakoglu. (2008) FDG-PET Evaluation of Response to Treatment. PET Clinics 3:1, pages 37-75.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.